Methyl 5-oxo-7-(((trifluoromethyl)sulfonyl)oxy)-1,2,3,5-tetrahydroindolizine-3-carboxylate

Catalog No. :
ACKYWL689
CAS No. :
1956310-54-5
Molecular Formula :
C11H10F3NO6S
Molecular Weight :
341.26

IUPAC Name:methyl 5-oxo-7-(((trifluoromethyl)sulfonyl)oxy)-1,2,3,5-tetrahydroindolizine-3-carboxylate

Methyl 5-oxo-7-(((trifluoromethyl)sulfonyl)oxy)-1,2,3,5-tetrahydroindolizine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$210.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-oxo-7-(((trifluoromethyl)sulfonyl)oxy)-1,2,3,5-tetrahydroindolizine-3-carboxylate
IUPAC Namemethyl 5-oxo-7-(((trifluoromethyl)sulfonyl)oxy)-1,2,3,5-tetrahydroindolizine-3-carboxylate
MDL No.MFCD29917088
Molecular FormulaC11H10F3NO6S
Molecular Weight341.26
SMILESO=C(C(N12)CCC2=CC(OS(=O)(C(F)(F)F)=O)=CC1=O)OC
InChI KeyUAKUKEWEPLTYNL-UHFFFAOYSA-N
Synonym1956310-54-5 | Methyl 5-oxo-7-(((trifluoromethyl)sulfonyl)oxy)-1,2,3,5-tetrahydroindolizine-3-carboxylate | methyl 5-oxo-7-(trifluoromethylsulfonyloxy)-2,3-dihydro-1H-indolizine-3-carboxylate | MFCD29917088 | AS-54995 | CS-0080173 | W11974 | Methyl5-oxo-7
CAS No.1956310-54-5
PubChem CID118798848

Synthetic Route by SureRoute

1. ACKYWL689 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKYWL689 route product structure diagram
    ACKYWL6891956310-54-5 In Stock
Inquiry

2. ACKYWL689 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAILX604 route compound structure diagram
    ACAILX60433454-82-9 In Stock
  4. Then
  5. ACKYWL689 route product structure diagram
    ACKYWL6891956310-54-5 In Stock
Inquiry

Comments (0)